A Randomized, Double-Blind, Placebo-Controlled Dose-Escalation Study to Determine the Safety and Efficacy of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Crohn's Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Monica E Luchi, MD
Celularity Incorporated
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cedars Sinai Medical Center, Inflammatory Bowel Disease Center
Los Angeles, California, United States
- University of Colorado Health Science Center
Denver, Colorado, United States
- University of Florida
Gainesville, Florida, United States
- University of Miami School of Medicine
Miami, Florida, United States
- Rochester General Hospital
Rochester, New York, United States
- University of Cincinnati Medical Center
Cincinnati, Ohio, United States
- Case Western Reserve University Hospitals of Cleveland
Cleveland, Ohio, United States
- Erlanger Baroness Hospital
Chattanooga, Tennessee, United States
- Vanderbilt - Ingram Cancer Center
Nashville, Tennessee, United States
- Baylor College of Medicine
Houston, Texas, United States
- University of Utah
Salt Lake City, Utah, United States
- Mcguire Veterans Affairs Medical Center
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2013
- Primary completion
- 30 Nov 2014
- Completion
- 30 Nov 2014
- Last update posted
- 1 Mar 2018
- Registered enrollment
- 14
- Registry id
- NCT01769755
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.